{"Title": "A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)", "Year": 2017, "Source": "Leukemia", "Volume": "31", "Issue": 1, "Art.No": null, "PageStart": 107, "PageEnd": 114, "CitedBy": 70, "DOI": "10.1038/leu.2016.176", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84978544451&origin=inward", "Abstract": "\u00a9 2017 Macmillan Publishers Limited, part of Springer Nature.This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). Relapsed and refractory multiple myeloma patients were randomized (1:1) to receive carfilzomib (10-min intravenous infusion; 20 mg/m 2 on days 1 and 2 of cycle 1; 27 mg/m 2 thereafter) or a control regimen of low-dose corticosteroids (84 mg of dexamethasone or equivalent corticosteroid) with optional cyclophosphamide (1400 mg) for 28-day cycles. The primary endpoint was overall survival (OS). Three-hundred and fifteen patients were randomized to carfilzomib (n=157) or control (n=158). Both groups had a median of five prior regimens. In the control group, 95% of patients received cyclophosphamide. Median OS was 10.2 (95% confidence interval (CI) 8.4-14.4) vs 10.0 months (95% CI 7.7-12.0) with carfilzomib vs control (hazard ratio=0.975; 95% CI 0.760-1.249; P=0.4172). Progression-free survival was similar between groups; overall response rate was higher with carfilzomib (19.1 vs 11.4%). The most common grade \u22653 adverse events were anemia (25.5 vs 30.7%), thrombocytopenia (24.2 vs 22.2%) and neutropenia (7.6 vs 12.4%) with carfilzomib vs control. Median OS for single-agent carfilzomib was similar to that for an active doublet control regimen in heavily pretreated RRMM patients.", "AuthorKeywords": null, "IndexKeywords": ["Adrenal Cortex Hormones", "Adult", "Aged", "Aged, 80 and over", "Anemia", "Cyclophosphamide", "Disease-Free Survival", "Female", "Humans", "Male", "Middle Aged", "Multiple Myeloma", "Neutropenia", "Oligopeptides", "Recurrence", "Salvage Therapy", "Survival Rate", "Thrombocytopenia"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84978544451", "SubjectAreas": [["Hematology", "MEDI", "2720"], ["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"57207606296": {"Name": "H\u00e1jek R.", "AuthorID": "57207606296", "AffiliationID": "60068908, 60025670", "AffiliationName": "University Hospital Ostrava, Faculty of Medicine, University of Ostrava"}, "22938960400": {"Name": "Pour L.", "AuthorID": "22938960400", "AffiliationID": "60068908, 60025670", "AffiliationName": "University Hospital Ostrava, Faculty of Medicine, University of Ostrava"}, "12775030700": {"Name": "Masszi T.", "AuthorID": "12775030700", "AffiliationID": "60068476", "AffiliationName": "St Istv\u00e1n and St L\u00e1szl\u00f3 Hospital of Budapest"}, "35305914000": {"Name": "Petrucci M.T.", "AuthorID": "35305914000", "AffiliationID": "60032350", "AffiliationName": "Sapienza University of Rome"}, "7103361944": {"Name": "Palumbo A.", "AuthorID": "7103361944", "AffiliationID": "60012259", "AffiliationName": "University of Torino"}, "6602445850": {"Name": "Rosi\u00f1ol L.", "AuthorID": "6602445850", "AffiliationID": "60030315", "AffiliationName": "Hospital Cl\u00ednic de Barcelona"}, "7103058110": {"Name": "Nagler A.", "AuthorID": "7103058110", "AffiliationID": "60011766", "AffiliationName": "Chaim Sheba Medical Center"}, "7102064249": {"Name": "Yong K.L.", "AuthorID": "7102064249", "AffiliationID": "60022148", "AffiliationName": "University College London Cancer Institute"}, "7006616023": {"Name": "Oriol A.", "AuthorID": "7006616023", "AffiliationID": "60028462, 60015633", "AffiliationName": "Institut Catal\u00e0 d'Oncologia, Hospital Germans Trias i Pujol"}, "8605163000": {"Name": "Minarik J.", "AuthorID": "8605163000", "AffiliationID": "60008462, 60003367", "AffiliationName": "University Hospital Olomouc and Medical Faculty of Palacky, University Olomouc"}, "55978800700": {"Name": "Dimopoulos M.A.", "AuthorID": "55978800700", "AffiliationID": "60028900", "AffiliationName": "National and Kapodistrian University of Athens"}, "6602330795": {"Name": "Maisnar V.", "AuthorID": "6602330795", "AffiliationID": "60018451", "AffiliationName": "Charles University Teaching Hospital, Hradec Kr\u00e1lov\u00e9"}, "7103169691": {"Name": "Rossi D.", "AuthorID": "7103169691", "AffiliationID": "60003668", "AffiliationName": "Amedeo Avogadro University of Eastern Piedmont"}, "6602531554": {"Name": "Kasparu H.", "AuthorID": "6602531554", "AffiliationID": "112907091", "AffiliationName": "Hospital Elisabethinen Linz"}, "56588849400": {"Name": "Van Droogenbroeck J.", "AuthorID": "56588849400", "AffiliationID": "106790833", "AffiliationName": "AZ Sint-Jan"}, "55666835200": {"Name": "Yehuda D.B.", "AuthorID": "55666835200", "AffiliationID": "60000087", "AffiliationName": "Hadassah Medical Center"}, "6701735183": {"Name": "Hardan I.", "AuthorID": "6701735183", "AffiliationID": "60022851", "AffiliationName": "Meir Medical Center"}, "12807410400": {"Name": "Jenner M.", "AuthorID": "12807410400", "AffiliationID": "60021722", "AffiliationName": "Southampton General Hospital"}, "23979185300": {"Name": "Calbecka M.", "AuthorID": "23979185300", "AffiliationID": "112635784", "AffiliationName": "Nicolaus Copernicus Hospital"}, "7402104036": {"Name": "D\u00e1vid M.", "AuthorID": "7402104036", "AffiliationID": "60004737", "AffiliationName": "University of P\u00e9cs"}, "7005915648": {"Name": "De La Rubia J.", "AuthorID": "7005915648", "AffiliationID": "60105170, 60032451", "AffiliationName": "University Hospital la Fe and Universidad Catolica de Valencia 'San Vicente Martir'"}, "55983174000": {"Name": "Drach J.", "AuthorID": "55983174000", "AffiliationID": "60011394", "AffiliationName": "Medical University of Vienna"}, "23102758200": {"Name": "Gasztonyi Z.", "AuthorID": "23102758200", "AffiliationID": "119053157", "AffiliationName": "Petz Alad\u00e1r Megyei Oktat\u00f3 K\u00f3rh\u00e1z, Vasv\u00e1ri P\u00e1l"}, "57190226609": {"Name": "G\u00f3rnik S.", "AuthorID": "57190226609", "AffiliationID": "119158653", "AffiliationName": "Zamojski Szpital Niepubliczny"}, "6701748692": {"Name": "Leleu X.", "AuthorID": "6701748692", "AffiliationID": "60017724", "AffiliationName": "Hopital Huriez, CHRU"}, "6602635086": {"Name": "Munder M.", "AuthorID": "6602635086", "AffiliationID": "60022135", "AffiliationName": "University Medicine Mainz"}, "56371583300": {"Name": "Offidani M.", "AuthorID": "56371583300", "AffiliationID": "60085015", "AffiliationName": "Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona"}, "6701832160": {"Name": "Zojer N.", "AuthorID": "6701832160", "AffiliationID": "60000713", "AffiliationName": "Center for Oncology Hematology, Outpatient Department and Palliative Care, Wilhelminenspital"}, "14834079000": {"Name": "Rajangam K.", "AuthorID": "14834079000", "AffiliationID": "60016020, 60001673", "AffiliationName": "Onyx Pharmaceuticals Inc., An Amgen Subsidiary"}, "57190224685": {"Name": "Chang Y.L.", "AuthorID": "57190224685", "AffiliationID": "60016020, 60001673", "AffiliationName": "Onyx Pharmaceuticals Inc., An Amgen Subsidiary"}, "57202475274": {"Name": "San-Miguel J.F.", "AuthorID": "57202475274", "AffiliationID": "60033320", "AffiliationName": "Cl\u00ednica Universidad de Navarra-CIMA-IDISNA"}, "55712017800": {"Name": "Ludwig H.", "AuthorID": "55712017800", "AffiliationID": "100796387", "AffiliationName": "Wilhelminen Cancer Research Institute"}}}